KCNN4 and colitis: Consistent with pharmacological inhibition studies, KCa3.1 KO mice are protected against developing severe colitis in mouse models of colitis induced by either T-cell transfer or TNBS (Di et al., 2010), further supporting a causative role of KCa3.1 in intestinal inflammation.